Gynecologic Cancers

Ursula Matulonis MD reviews key gynecologic cancer findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • RT + CT vs RT for EC
    Combination Adjuvant Chemotherapy + Radiation Therapy vs Radiation Alone for High Risk Endometrial Carcinoma: Final Report From PORTEC-3
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2017

    Expires: June 03, 2018

  • Nivo in R/M GYN Cancers
    CheckMate 358: Phase I/II Evaluation of Nivolumab Monotherapy in Virus-Associated, Recurrent/Metastatic Gynecologic Cancers
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2017

    Expires: June 03, 2018

  • LION: LNE for Advanced Ovarian Cancer
    LION (Phase III Trial): Lymphadenectomy for LN-Negative Advanced Ovarian Cancer Following Complete Resection
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2017

    Expires: June 04, 2018

  • SOLO2: Olaparib in Ovarian Cancer
    SOLO2: Safety, HRQoL With Maintenance Olaparib in Germline BRCA-Mutated Platinum-Sensitive Relapsed Serous Ovarian Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 13, 2017

    Expires: June 12, 2018

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology